• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全切除胶质母细胞瘤的分次间放疗靶区变化与自适应放疗

Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.

机构信息

Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

出版信息

J Korean Med Sci. 2013 Aug;28(8):1233-7. doi: 10.3346/jkms.2013.28.8.1233. Epub 2013 Jul 31.

DOI:10.3346/jkms.2013.28.8.1233
PMID:23960453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3744714/
Abstract

This study aimed to evaluate the effects of volume adapted re-planning for radiotherapy (RT) after gross total resection (GTR) for glioblastoma. Nineteen patients with glioblastoma who underwent GTR and postoperative RT were analyzed. The volumes of the surgical cavity on computed tomography (CT) obtained one day after GTR (CT0), the first RT simulation CT (sim-CT1), and the second simulation CT for the boost RT plan (sim-CT2) were compared. The boost RT plan was based on the surgical cavity observed on the sim-CT2 (boost RTP2) and was compared with that based on the surgical cavity observed on the sim-CT1 (boost RTP1). The volume reduction ratios were 14.4%-51.3% (median, 29.0%) between CT0 and sim-CT1 and -7.9%-71.9% (median, 34.9%) between sim-CT1 and sim-CT2 (P < 0.001). The normal brain volumes in boost RTP1 were significantly reduced in boost RTP2, especially at high dose levels. Target volume in sim-CT2 which was not covered with the boost RTP1, developed in five cases (26.3%). The surgical cavity volume was reduced following surgery in patients with glioblastoma who underwent GTR. The application of volume-adapted re-planning during RT could decrease the irradiated volume of normal brain and prevent a target miss for boost RT.

摘要

本研究旨在评估胶质母细胞瘤患者行全切除术后(GTR)容积自适应再计划放疗(RT)的效果。分析了 19 例接受 GTR 及术后 RT 的胶质母细胞瘤患者。比较了 GTR 后第 1 天获得的 CT(CT0)、首次 RT 模拟 CT(sim-CT1)和二次推量 RT 计划模拟 CT(sim-CT2)的手术腔体积。推量 RT 计划基于 sim-CT2 上观察到的手术腔(boost RTP2),并与基于 sim-CT1 上观察到的手术腔(boost RTP1)进行比较。CT0 与 sim-CT1 之间的体积减少率为 14.4%-51.3%(中位数为 29.0%),sim-CT1 与 sim-CT2 之间的体积减少率为-7.9%-71.9%(中位数为 34.9%)(P<0.001)。在 boost RTP2 中,boost RTP1 中正常脑体积明显减少,尤其是在高剂量水平。5 例(26.3%)患者在 sim-CT2 中出现 boost RTP1 未覆盖的靶区。胶质母细胞瘤患者行 GTR 后手术腔体积缩小。在 RT 中应用容积自适应再计划可以减少正常脑的照射体积,防止推量 RT 靶区遗漏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/d07075a83b37/jkms-28-1233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/d33b1451832b/jkms-28-1233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/61c87f6520bc/jkms-28-1233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/8b126c3c2e96/jkms-28-1233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/d07075a83b37/jkms-28-1233-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/d33b1451832b/jkms-28-1233-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/61c87f6520bc/jkms-28-1233-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/8b126c3c2e96/jkms-28-1233-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/804c/3744714/d07075a83b37/jkms-28-1233-g004.jpg

相似文献

1
Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.全切除胶质母细胞瘤的分次间放疗靶区变化与自适应放疗
J Korean Med Sci. 2013 Aug;28(8):1233-7. doi: 10.3346/jkms.2013.28.8.1233. Epub 2013 Jul 31.
2
A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma.前瞻性比较胶质母细胞瘤放疗中自适应和固定boost 计划。
Radiat Oncol. 2022 Feb 22;17(1):40. doi: 10.1186/s13014-022-02007-4.
3
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.局限性边缘放疗联合替莫唑胺治疗胶质母细胞瘤的失败模式。
Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):130-6. doi: 10.1016/j.ijrobp.2009.10.048. Epub 2010 Apr 14.
4
Repeat computed tomography simulation to assess lumpectomy cavity volume during whole-breast irradiation.重复计算机断层扫描模拟以评估全乳照射期间乳房肿瘤切除术腔体积。
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):751-6. doi: 10.1016/j.ijrobp.2008.11.024. Epub 2009 Mar 14.
5
Simultaneous integrated boost in breast conserving radiotherapy: is replanning necessary following tumor bed change?保乳放疗中的同步整合增量:肿瘤床变化后是否需要重新计划?
Technol Cancer Res Treat. 2013 Apr;12(2):115-22. doi: 10.7785/tcrt.2012.500309. Epub 2012 Oct 19.
6
Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume.胶质母细胞瘤放化疗联合FET PET引导下的增敏放疗及模拟以优化放疗靶区后的复发模式
Radiat Oncol. 2016 Jun 24;11:87. doi: 10.1186/s13014-016-0665-z.
7
Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.模式的失败和比较不同的目标体积描绘在患者胶质母细胞瘤治疗与适形放疗加上同期和辅助替莫唑胺。
Radiother Oncol. 2010 Dec;97(3):377-81. doi: 10.1016/j.radonc.2010.08.020. Epub 2010 Sep 18.
8
Transcranial sonography: integration into target volume definition for glioblastoma multiforme.经颅超声检查:整合至多形性胶质母细胞瘤的靶区体积定义中
Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):565-71. doi: 10.1016/s0360-3016(00)00565-4.
9
Evaluation of variability in target volume delineation for newly diagnosed glioblastoma: a multi-institutional study from the Korean Radiation Oncology Group.新诊断胶质母细胞瘤靶区勾画的变异性评估:韩国放射肿瘤学组的一项多机构研究
Radiat Oncol. 2015 Jul 2;10:137. doi: 10.1186/s13014-015-0439-z.
10
Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.基于 FET-PET 自动勾画靶区的容积整合调强放疗或三维适形放疗对比多形性胶质母细胞瘤的剂量学研究。
Radiat Oncol. 2009 Nov 23;4:57. doi: 10.1186/1748-717X-4-57.

引用本文的文献

1
Timing of Planning Magnetic Resonance Imaging and Patient Selection for Adaptive Radiation Therapy in Newly Diagnosed High-Grade Glioma.新诊断高级别胶质瘤中自适应放射治疗的计划磁共振成像时机及患者选择
Int J Radiat Oncol Biol Phys. 2025 Jul 1;122(3):561-571. doi: 10.1016/j.ijrobp.2025.03.037. Epub 2025 Mar 28.
2
Adoption of Hybrid MRI-Linac Systems for the Treatment of Brain Tumors: A Systematic Review of the Current Literature Regarding Clinical and Technical Features.混合动力 MRI-直线加速器系统在脑肿瘤治疗中的应用:当前文献中关于临床和技术特征的系统评价。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231199286. doi: 10.1177/15330338231199286.
3

本文引用的文献

1
Radiation dose-volume effects in the brain.脑的放射剂量-体积效应。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S20-7. doi: 10.1016/j.ijrobp.2009.02.091.
2
Implications of contrast-enhanced CT-based and MRI-based target volume delineations in radiotherapy treatment planning for brain tumors.基于对比增强CT和基于MRI的靶区勾画在脑肿瘤放射治疗计划中的意义。
J Cancer Res Ther. 2008 Jan-Mar;4(1):9-13. doi: 10.4103/0973-1482.39598.
3
Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.
应用放射治疗体积分析流水线评估磁共振波谱成像引导自适应放疗在胶质母细胞瘤中的应用价值。
Tomography. 2023 May 21;9(3):1052-1061. doi: 10.3390/tomography9030086.
4
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy.用于高精度MRI引导的颅内放射治疗的经验性计划靶区建模
Clin Transl Radiat Oncol. 2023 Jan 16;39:100582. doi: 10.1016/j.ctro.2023.100582. eCollection 2023 Mar.
5
Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy.分子标志物时代及MRI引导下的适应性放射治疗中的胶质母细胞瘤成像
J Clin Med. 2022 Oct 10;11(19):5961. doi: 10.3390/jcm11195961.
6
Pattern of Recurrence of Glioblastoma Versus Grade 4 IDH-Mutant Astrocytoma Following Chemoradiation: A Retrospective Matched-Cohort Analysis.放化疗后胶质母细胞瘤与 IDH 突变型 4 级星形细胞瘤复发模式的回顾性匹配队列分析。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221109650. doi: 10.1177/15330338221109650.
7
Updates in IDH-Wildtype Glioblastoma.IDH 野生型胶质母细胞瘤的最新进展。
Neurotherapeutics. 2022 Oct;19(6):1705-1723. doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31.
8
Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses.胶质母细胞瘤的有限野自适应放疗:靶区体积和危及器官剂量的变化
Radiat Oncol J. 2022 Mar;40(1):9-19. doi: 10.3857/roj.2021.00542. Epub 2022 Mar 28.
9
A prospective comparison of adaptive and fixed boost plans in radiotherapy for glioblastoma.前瞻性比较胶质母细胞瘤放疗中自适应和固定boost 计划。
Radiat Oncol. 2022 Feb 22;17(1):40. doi: 10.1186/s13014-022-02007-4.
10
Study on the Appropriate Timing of Postoperative Adaptive Radiotherapy for High-Grade Glioma.高级别胶质瘤术后适形放疗时机的研究
Cancer Manag Res. 2021 Apr 28;13:3561-3572. doi: 10.2147/CMAR.S300094. eCollection 2021.
新诊断的多形性胶质母细胞瘤在三维适形放射治疗后复发模式与放疗前磁共振波谱结果的相关性分析
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):381-9. doi: 10.1016/j.ijrobp.2007.03.019. Epub 2007 May 21.
4
Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma.胶质母细胞瘤放疗临床靶区勾画中瘤周水肿的评估
Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):144-50. doi: 10.1016/j.ijrobp.2006.12.009. Epub 2007 Feb 15.
5
Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.建立辐射剂量测定模型以预测包括髓母细胞瘤在内的中枢神经系统胚胎性肿瘤患儿的认知结局。
Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):210-21. doi: 10.1016/j.ijrobp.2005.10.038. Epub 2006 Feb 10.
6
Target definition in the thorax and central nervous system.
Semin Radiat Oncol. 2005 Jul;15(3):146-56. doi: 10.1016/j.semradonc.2005.01.001.
7
The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme.
Technol Cancer Res Treat. 2004 Jun;3(3):303-7. doi: 10.1177/153303460400300308.
8
Target volumes in radiotherapy for high-grade malignant glioma of the brain.脑高级别恶性胶质瘤放射治疗中的靶区体积
Radiother Oncol. 2000 Aug;56(2):151-6. doi: 10.1016/s0167-8140(00)00216-4.
9
3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.胶质母细胞瘤在CT引导下术后放疗后的三维复发模式
Radiother Oncol. 1999 Oct;53(1):53-7. doi: 10.1016/s0167-8140(99)00117-6.
10
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.超分割放射治疗与双氯乙基亚硝脲治疗恶性胶质瘤——在1.2 Gy每日两次分割剂量达72.0 Gy时观察到的可能优势:放射治疗肿瘤学组8302方案报告
Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):193-207. doi: 10.1016/0360-3016(93)90340-2.